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Objective: The objective of this study was to evaluate trends in outcomes of inpatient mortality, surgical complications,
charges, and length of stay stratiﬁed according to open vs endovascular revascularization and amputation status in
patients admitted to the hospital with diabetic foot ulcers (DFUs).
Methods: Inpatient discharge records from the Agency for Healthcare Research and Quality Healthcare Cost and Utili-
zation Project were used in this retrospective cohort study spanning 2001 to 2010. Multivariate regression analyses were
used to simultaneously control for patient demographic and socioeconomic attributes, hospital characteristics, and co-
morbid case-mix disease severity.
Results: During the study period, 2.5 million inpatient DFU cases were observed, of which 412,051 (16.5%) involved
amputation (34.8% major, 61.2% minor). Overall, 211,534 (8.5%) of DFU cases underwent revascularization (43.5%
open, 51.1% endovascular treatment [EVT], 5.4% both). From 2001 vs 2010, the volume of open procedures decreased
34.9%, and EVT volume increased 197.1%. The percentage of amputations for DFUs remained relatively unchanged, and
a major:minor ratio of 0.534 was observed among all cases. Across speciﬁc procedure type and amputation status,
multivariate analyses indicated equal or decreased inpatient mortality and lengths of stay since 2001, and inﬂation-
adjusted charges generally increased. The presence of a surgical complication, however, was observed to increase by
>50% for open procedures involving minor amputations and >30% for open procedures involving no amputations.
Because of many potential factors, surgical complications were noted to exceed approximately 900% among cases of EVT
involving major amputations beginning in 2007 relative to 2001.
Conclusions: This nationally-representative investigation found that DFU admissions are common, long, and costly (often
>$100,000 per case), with a marked shift having occurred from open bypass to EVT. Although hospital mortality and
length of stay either remained the same or have decreased signiﬁcantly, an increase in procedure-speciﬁc surgical com-
plications was observed across several intervention categories. (J Vasc Surg 2014;60:1255-65.)Diabetic foot ulcers (DFUs) are a serious medical con-
dition that develop in approximately one-quarter of per-
sons with diabetes, with approximately half becoming
infected and requiring hospitalization and one-ﬁfth culmi-
nating in amputation.1,2 The mortality rate after DFU-
related amputations has been reported to exceed most
malignancies, ranging from 39% to 80% after 5 years.1,3,4
Additionally, up to one-third of all diabetes treatment costs
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overall, previous researchers have sought to investigate
changes in the use of revascularization procedures at the
population level over time, and reported that large in-
creases in endovascular treatment (EVT) were coupled
with decreases in open procedures in recent years.6-10
Results of studies have suggested reductions in amputation
rates and speciﬁc types of surgical complications, although
other empirical analyses have reported no change in ampu-
tations over time despite the increased use of less invasive
techniques.8-10
Only limited analyses have described either long-term
patterns of revascularization among high-risk DFU cases
or associated burdens of illness, particularly those that
incorporated any changes in overall disease complexity
that might present to inpatient settings. The purpose of
this investigation was therefore to assess clinical and eco-
nomic outcomes, general case-mix complexity, and use of
revascularization among hospital inpatient DFU cases and
associated amputations in the United States from 2001
to 2010. This study’s speciﬁc objectives were to evaluate
the trends in outcomes of inpatient mortality, surgical com-
plications, charges, and length of stay (LOS), as a function
of patient demographic and hospital characteristics, and co-
morbid disease status stratiﬁed according to open proce-
dures vs EVT and amputation status.1255
Fig. Open bypass and endovascular (EVT) procedures based on
volume and percent involving amputation, 2001 to 2010.
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In this nationally-representative retrospective cross-
sectional study, we used inpatient discharge records from
the Agency for Healthcare Research and Quality Health-
care Cost and Utilization Project (HCUP) Nationwide
Inpatient Sample, a large scale dataset that generalizes to
the approximately 39 million inpatient cases that occur
annually in the United States.11 A 10-year time horizon
was deﬁned from 2001 to 2010 to capture patterns of
care focusing on clinical outcomes of surgical complications
and inpatient mortality and economic outcomes of
inﬂation-adjusted charges (USD, 2012) reﬂecting costs
from the perspective of the payer and resource utilization
based on LOS. Because of the anonymized nature of data
within HCUP, this study was designated as exempt from
Human Subjects Protection and Institutional Review
Board approval.11
The study inclusion criteria were cases of DFUs among
adults $18 years of age. Because no diagnosis code exists
for a DFU, the validated procedure was used based on
Sohn et al, wherein International Classiﬁcation of Diseases,
Ninth Edition (ICD-9)-Clinical Manifestation codes of
diabetes (ICD-9 250.xx) in conjunction with either
707.1x (ulcer of lower limb, except pressure ulcer) or
707.9 (chronic ulcer, unspeciﬁed).12Open revascularization
procedures were deﬁned by ICD-9 39.25 (aorta-iliac-
femoral bypass) and ICD-9 39.29 (other peripheral vascular
shunt or bypass), and EVT included ICD-9 39.50 (angio-
plasty or atherectomy of other noncoronary vessel) and
ICD-9 39.90 (insertion of non-drug-eluting peripheral
vessel stent).Major amputations were deﬁned as above ankle
with ICD-9 84.13 through 84.19 (ankle disarticulation,
through malleoli of tibia and ﬁbula, below knee, of knee,
above knee, hip, abdominopelvic amputation), and minor
procedures involved ICD-9 84.10 to 84.12 (amputation
of lower limb, toe, through foot). Peri- and postoperative
surgical complications were deﬁned to include cardiac
(ICD-9 997.1: cardiac complications), perioperative stroke
(997.02: iatrogenic cerebrovascular infarction or hemor-
rhage), respiratory (997.3 and 518.5: respiratory complica-
tions, pulmonary insufﬁciency after trauma and surgery),
bleeding (998.1 and 285.1: hemorrhage or hematoma or
seroma complicating a procedure, acute posthemorrhagic
anemia), infection (998.5, 998.59, and 996.62: postopera-
tive infection, infection due to vascular device/implant/
graft), and shock (998.0: postoperative shock).
Inferential statistical analyses involved a multivariate
assessment of stratiﬁed amputation and procedure catego-
rizations that controlled for year of admission, patient so-
cioeconomic and demographic factors (ie, age, sex,
income quartile), hospital characteristics (ie, teaching sta-
tus, geographic region, bed size, urban/rural location),
and the Deyo-Charlson Comorbidity Index (ie, a validated
measure of case-mix disease severity).13 Stratiﬁcation of an-
alyses was undertaken using revascularization procedure
type (ie, open, EVT) and amputation (ie, major, minor,
none). A generalized linear model framework withmaximum likelihood estimation was used, wherein the:
(1) presence of a surgical complication was assessed using
binomial/Bernoulli (logistic) regression; (2) total number
of surgical complications was assessed using a Poisson
regression with log-link; (3) charges were assessed using a
gamma regression and log-link; and (4) LOS used a gener-
alized negative binomial with log-link.14,15All multivariate
ﬁndings were interpreted consistently as relative risk mea-
sures (eg, <1.0 indicating a reduced likelihood, ¼1.0 indi-
cating no difference in likelihood, and >1.0 indicating an
increased likelihood), more speciﬁcally as: odds ratios
(ORs) for generalized binomial (logistic) regression; inci-
dence rate ratios (IRRs) for Poisson and negative binomial
regression; and exponentiated beta coefﬁcient estimates for
gamma regression.15 Because of the large number of mul-
tiple comparisons drawn across the study’s generalized
linear model analytic subgroups, the Simes procedure was
used to correct for false discovery rates, yielding a critical
P-value of .023 for statistical signiﬁcance.16 Additionally,
a Taylor-series approach was used to ensure robust and ac-
curate standard error determination that also incorporated
appropriate statistical weighting to yield nationally-
representative results based on HCUP’s complex survey















Age 68.6 (611.2) 68.6 (611.9) 67.9 (610.8) 68.6 (611.5)
Charges (U.S., 2012) $90,546 (690,355) $87,961 (681,200) $131,116 (6107,545) $91,398 (687,361)
Total national bill (U.S., 2012) $8.15 billion $9.38 billion $1.46 billion $18.99 billion
Female sex 39.6% (n ¼ 36,425) 42.9% (n ¼ 46,383) 40.1% (n ¼ 4561) 41.3% (n ¼ 87,369)
Income quartile, %
0-25 23.6% (n ¼ 21,309) 30.3% (n ¼ 32,058) 27.7% (n ¼ 3089) 27.2% (n ¼ 56,455)
26-50 25.3% (n ¼ 22,837) 26.1% (n ¼ 27,621) 25.7% (n ¼ 2852) 25.7% (n ¼ 53,309)
51-75 24.0% (n ¼ 21,667) 22.0% (n ¼ 23,225) 22.9% (n ¼ 2552) 22.9% (n ¼ 47,445)
76-100 27.1% (n ¼ 24,441) 21.6% (n ¼ 22,882) 24.0% (n ¼ 2676) 24.1% (n ¼ 50,000)
Hospital characteristics
Teaching facility 54.2% (n ¼ 49,824) 52.6% (n ¼ 56,603) 55.6% (n ¼ 6321) 53.5% (n ¼ 112,749)
Hospital region
Northeast 27.5% (n ¼ 25,301) 21.6% (n ¼ 23,306) 26.7% (n ¼ 3034) 24.4% (n ¼ 51,642)
Midwest 22.7% (n ¼ 20,931) 25.4% (n ¼ 27,443) 21.4% (n ¼ 2435) 24.0% (n ¼ 50,808)
South 33.2% (n ¼ 30,540) 37.3% (n ¼ 40,363) 36.3% (n ¼ 4127) 35.5% (n ¼ 75,030)
West 16.6% (n ¼ 15,257) 15.7% (n ¼ 17,013) 15.7% (n ¼ 1784) 16.1% (n ¼ 34,054)
Bed size
Small 8.6% (n ¼ 7940) 9.2% (n ¼ 9918) 8.6% (n ¼ 980) 8.9% (n ¼ 18,837)
Medium 22.7% (n ¼ 20,823) 21.7% (n ¼ 23,328) 21.2% (n ¼ 2414) 22.1% (n ¼ 46,564)
Large 68.7% (n ¼ 63,116) 69.1% (n ¼ 74,363) 70.1% (n ¼ 7968) 69.0% (n ¼ 145,447)
Urban location 93.5% (n ¼ 85,888) 93.2% (n ¼100,326) 92.2% (n ¼ 10,472) 93.3% (n ¼ 196,687)
Inpatient case characteristics
LOS 12.0 (610.5) 9.4 (610.1) 14.7 (611.6) 10.9 (611.5)
No. of diagnoses 10.8 (64.3) 12.0 (64.9) 12.0 (64.6) 11.5 (64.7)
No. of procedures 4.1 (62.6) 5.8 (62.7) 7.3 (63.1) 5.1 (62.9)
Deyo-Charlson Comorbidity Index 2.2 (61.3) 2.5 (61.5) 2.3 (61.3) 2.4 (61.4)
Year
2001 12.5% (n ¼ 11,483) 4.2% (n ¼ 4583) 7.2% (n ¼ 816) 8.0% (n ¼ 16,882)
2002 12.6% (n ¼ 11,608) 4.2% (n ¼ 4573) 9.3% (n ¼ 1057) 8.1% (n ¼ 17,238)
2003 12.2% (n ¼ 11,183) 5.8% (n ¼ 6313) 10.1% (n ¼ 1149) 8.8% (n ¼ 18,645)
2004 11.2% (n ¼ 10,344) 7.2% (n ¼ 7793) 10.0% (n ¼ 1134) 9.1% (n ¼ 19,271)
2005 9.8% (n ¼ 9064) 8.5% (n ¼ 9243) 10.2% (n ¼ 1155) 9.2% (n ¼ 19,462)
2006 9.0% (n ¼ 8268) 12.9% (n ¼ 13,979) 11.2% (n ¼ 1279) 11.1% (n ¼ 23,467)
2007 8.7% (n ¼ 8018) 14.4% (n ¼ 15,534) 11.0% (n ¼ 1252) 11.7% (n ¼ 24,804)
2008 8.4% (n ¼ 7717) 14.4% (n ¼ 15,538) 11.4% (n ¼ 1296) 11.6% (n ¼ 24,549)
2009 8.1% (n ¼ 7450) 14.5% (n ¼ 15,705) 9.9% (n ¼ 1130) 11.5% (n ¼ 24,285)
2010 7.5% (n ¼ 6893) 13.8% (n ¼ 14,926) 9.8% (n ¼ 1112) 10.8% (n ¼ 22,931)
LOS, Length of stay.
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(Cary, NC) and Stata SE version 12.1 (College Station,
Tex).
RESULTS
Descriptive statistics. A total of 2,497,363 inpatient
DFU cases were observed from 2001 to 2010 across
388.4 million total inpatient admissions, with 16.5% (n ¼
412,051) involving amputations (major ¼ 34.8%,
minor ¼ 65.2%) and 8.5% (n ¼ 211,534) involving a revas-
cularization procedure (open only ¼ 43.5%, EVT only ¼
51.1%, combination ¼ 5.4%). Of the 143,470 major ampu-
tations, 6.7% (n ¼ 9600) involved revascularization during
the same hospital stay (open only ¼ 29.8%, EVT only ¼
63.5%, combination ¼ 6.7%) vs 15.1% (n ¼ 40,422) of
the 268,520 minor amputations (open only ¼ 44.9%,
EVT only ¼ 44.2%, combination ¼ 6.9%). Overall, themajor:minor amputation ratio was 0.534, and those
involving any revascularization equaled 0.237.
In a comparison of 2001 with 2010 (Fig), the volume
of overall DFU cases involving any open procedure
decreased 34.9% (from 12,300 to 8005), and EVT volume
increased 197.1% (from 5399 to 16,038). Within this pop-
ulation, minor amputations increased 48.5% (from 21,545
to 32,000), and major amputations increased 7.7% (from
13,067 to 14,069 cases). Among amputation-only cases,
in a comparison of 2001 vs 2010, open volume decreased
27.3% (from 2878 to 2091) and EVT increased 180.3%
(from 1077 to 4096), and was relatively ﬂat as a percentage
of DFU cases (Fig). Importantly, an increasing case-mix
severity was seen for amputations with associated vascular
procedures from 2001 to 2010; the Deyo-Charlson Co-
morbidity Index increased slightly but signiﬁcantly for ma-
jor amputations (from 2.25 to 3.04; P < .001) and for
Table II. Descriptive statistics, stratiﬁed according to single procedure and amputation type
Variable
Open bypass procedure only,
major amputation (n ¼ 2865)
Open bypass procedure only,
minor amputation (n ¼ 19,750)
Open bypass procedure only,
no amputation (n ¼ 69,414)
Patient characteristics
Age 67.0 (610.9) 67.5 (611.2) 69.0 (611.2)
Charges (U.S., 2012) $194,413 (6170,938) $118,568 (610,591) $78,253 (674,967)
Total national bill (U.S., 2012) $0.55 billion $2.29 billion $5.31 billion
Female sex 39.9% (n ¼ 1144) 33.7% (n ¼ 6663) 41.2% (n ¼ 28,617)
Income quartile, %
0-25 28.8% (n ¼ 807) 24.7% (n ¼ 4781) 23.1% (n ¼ 15,721)
26-50 23.9% (n ¼ 670) 24.3% (n ¼ 4708) 25.6% (n ¼ 17,459)
51-75 23.6% (n ¼ 660) 24.6% (n ¼ 4768) 23.8% (n ¼ 16,239)
76-100 23.8% (n ¼ 667) 26.3% (n ¼ 5088) 27.4% (n ¼ 18,687)
Hospital characteristics
Teaching facility 58.3% (n ¼ 1667) 54.7% (n ¼ 10795) 53.9% (n ¼ 37362)
Hospital region
Northeast 29.1% (n ¼ 834) 30.3% (n ¼ 5985) 26.6% (n ¼ 18,482)
Midwest 19.1% (n ¼ 546) 20.7% (n ¼ 4086) 23.5% (n ¼ 16,298)
South 36.2% (n ¼ 1038) 33.6% (n ¼ 6640) 32.9% (n ¼ 22,863)
West 15.6% (n ¼ 447) 15.4% (n ¼ 3039) 17.0% (n ¼ 11,771)
Bed size
Small 6.4% (n ¼ 184) 8.4% (n ¼ 1658) 8.8% (n ¼ 6098)
Medium 23.8% (n ¼ 680) 23.0% (n ¼ 4544) 22.5% (n ¼ 15,599)
Large 69.8% (n ¼ 1997) 68.6% (n ¼ 13,521) 68.7% (n ¼ 47,598)
Urban location 94.7% (n ¼ 2710) 93.9% (n ¼ 18,512) 93.3% (n ¼ 64,667)
Inpatient case characteristics
LOS 27.2 (610.9) 16.7 (610.9) 10.1 (68.6)
No. of diagnoses 12.7 (64.9) 11.6 (64.4) 10.5 (64.1)
No. of procedures 6.7 (63.2) 5.6 (62.6) 3.6 (62.4)
Deyo-Charlson Comorbidity Index 2.5 (61.3) 2.4 (61.3) 2.2 (61.3)
Year
2001 11.5% (n ¼ 331) 11.7% (n ¼ 2316) 12.7% (n ¼ 8837)
2002 13.0% (n ¼ 372) 13.2% (n ¼ 2611) 12.4% (n ¼ 8624)
2003 9.8% (n ¼ 181) 12.9% (n ¼ 2555) 12.0% (n ¼ 8346)
2004 12.9% (n ¼ 371) 11.5% (n ¼ 2272) 11.1% (n ¼ 7702)
2005 10.2% (n ¼ 293) 9.8% (n ¼ 1941) 9.8% (n ¼ 6829)
2006 11.7% (n ¼ 336) 8.5% (n ¼ 1671) 9.0% (n ¼ 6261)
2007 8.2% (n ¼ 236) 9.0% (n ¼ 1778) 8.6% (n ¼ 6004)
2008 7.9% (n ¼ 227) 8.0% (n ¼ 1583) 8.5% (n ¼ 5907)
2009 7.0% (n ¼ 200) 7.5% (n ¼ 1488) 8.3% (n ¼ 5763)
2010 7.6% (n ¼ 217) 7.8% (n ¼ 1535) 7.4% (n ¼ 5141)
LOS, Length of stay.
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justed mean charges per admission also increased by 25.5%
(from $104,839 to $131,554, P < .001) and the mean
LOS decreased by 22.5% (from 18.4 to 14.2; P < .001).
Inpatient amputation-related mortality was generally low
across all DFU cases, involving amputation at 1.7% and
decreased in total cases by 19.1% (from 749 [4.4%] to
606 [2.6%]; P < .001). The mortality rate for major ampu-
tation was 6.3% (open ¼ 6.3%, EVT ¼ 6.3%; P ¼ .963 [not
signiﬁcant]) vs 1.3% for minor amputation (open ¼ 1.4%,
EVT ¼ 1.2%; P ¼ .162 [not signiﬁcant]). The overall pres-
ence of any key surgical complications summed to 10.1%,
increasing slightly from 10.2% to 10.8% by 2010, repre-
senting a small, yet statistically signiﬁcant, proportional
change (P < .023). In Tables I to IV, descriptive statistics
for DFU cases with revascularization according to proce-
dure alone (Tables I and III) and additionally according
to amputation type (Tables II and IV) are shown; in Fig,
revascularization procedure volume and percentageinvolving amputation across the study’s time frame are
shown.
Multivariate analysis. Based on an initial assessment
of crude, unadjusted, descriptive statistics in an assess-
ment of open vs EVT across the 2001 to 2010 time
horizon, open procedures generally appeared to have a
higher rate of overall surgical complications, similar
to slightly greater inpatient mortality, charges, and a
longer LOS. In controlling for other factors (ie, patient
demographic and hospital characteristics, case-mix
severity), results are shown for the adjusted multivariate
analyses of procedure type according to amputation sta-
tus for clinical (Table V) and economic outcomes
(Table VI).
Concerning adjusted analyses of clinical outcomes from
2001 to 2010 (Table V), signiﬁcant increases (ie, P value
less than the Simes false discovery rate of P < .023) in
the presence of any surgical complication from 2001
exceeding 50% were noted for open procedures involving
Endovascular procedure only,
major amputation (n ¼ 6096)
Endovascular procedure only,
minor amputation (n ¼ 17,882)
Endovascular procedure only,
no amputation (n ¼ 84,147)
67.0 (610.9) 66.8 (612.0) 69.2 (611.8)
$165,225 (6132,324) $111,015 (686,350) $77,523 (670,531)
$0.99 billion $1.95 billion $6.44 billion
40.5% (n ¼ 2471) 35.0% (n ¼ 6265) 44.7% (n ¼ 37,647)
32.3% (n ¼ 1922) 30.2% (n ¼ 5260) 30.2% (n ¼ 24,877)
27.7% (n ¼ 1648) 25.4% (n ¼ 4423) 26.1% (n ¼ 21,550)
21.8% (n ¼ 1296) 21.9% (n ¼ 3813) 22.0% (n ¼ 18,116)
18.2% (n ¼ 1079) 22.5% (n ¼ 3928) 21.7% (n ¼ 17,875)
55.7% (n ¼ 3380) 53.8% (n ¼ 9571) 52.1% (n ¼ 43652)
18.0% (n ¼ 1096) 22.3% (n ¼ 3990) 21.7% (n ¼ 18,220)
22.1% (n ¼ 1347) 23.8% (n ¼ 4257) 26.0% (n ¼ 21,839)
41.9% (n ¼ 2557) 39.1% (n ¼ 6988) 36.6% (n ¼ 30,817)
18.0% (n ¼ 1096) 14.8% (n ¼ 2647) 15.8% (n ¼ 13,271)
8.6% (n ¼ 524) 8.8% (n ¼ 1563) 9.3% (n ¼ 7831)
23.4% (n ¼ 1422) 21.4% (n ¼ 3798) 21.6% (n ¼ 18,107)
67.9% (n ¼ 4121) 69.9% (n ¼ 12,427) 69.0% (n ¼ 57,815)
92.7% (n ¼ 5622) 93.3% (n ¼ 16,690) 93.1% (n ¼ 78,014)
21.1 (615.1) 13.7 (69.5) 7.7 (68.9)
14.2 (65.5) 13.2 (65.0) 11.53 (64.7)
7.8 (63.3) 6.9 (62.7) 5.4 (62.5)
2.9 (61.5) 2.6 (61.5) 2.5 (61.5)
3.8% (n ¼ 234) 3.4% (n ¼ 612) 4.4% (n ¼ 3736)
4.7% (n ¼ 287) 3.6% (n ¼ 638) 4.3% (n ¼ 3648)
7.9% (n ¼ 481) 5.4% (n ¼ 957) 5.8% (n ¼ 4875)
6.2% (n ¼ 378) 6.7% (n ¼ 1195) 7.4% (n ¼ 6220)
9.1% (n ¼ 553) 8.5% (n ¼ 1513) 8.5% (n ¼ 7176)
13.5% (n ¼ 822) 12.1% (n ¼ 2165) 13.0% (n ¼ 10,933)
15.4% (n ¼ 938) 13.8% (n ¼ 2463) 14.4% (n ¼ 12,133)
11.2% (n ¼ 680) 14.2% (n ¼ 2543) 14.6% (n ¼ 12,313)
14.6% (n ¼ 889) 16.1% (n ¼ 2872) 14.2% (n ¼ 11,943)
13.7% (n ¼ 833) 16.3% (n ¼ 2923) 13.3% (n ¼ 11,169)
Table II. Continued.
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OR2010 ¼ 1.74) and exceeding 30% for open procedures
involving no amputations (OR2008 ¼ 1.64, OR2009 ¼
1.37, OR2010 ¼ 1.53). A marked and signiﬁcant increase
in any surgical complication was observed for EVT use in
major amputations beginning in 2007 (OR2007 ¼ 11.27,
OR2009 ¼ 11.36, OR2010 ¼ 11.80).
Consistent with the aforementioned ﬁndings, the total
number of surgical complications (Table V) was signiﬁ-
cantly greater (ie, P value less than the Simes false discovery
rate of P < .023) for open procedures involving minor am-
putations exceeding 50% beginning in 2008 (IRR2008 ¼
1.52, IRR2009 ¼ 1.56, IRR2010 ¼ 1.74) and more than
33% for open procedures involving no amputation begin-
ning in 2008 (IRR2008 ¼ 1.53, IRR2009 ¼ 1.33,
IRR2010 ¼ 1.43). Large, statistically signiﬁcant increases
in the total number of surgical complications exceeding
approximately $900% were observed for EVT involving
major amputations for several years vs 2001 (IRR2007 ¼
9.99, IRR2009 ¼ 10.64, IRR2010 ¼ 10.70).The multivariate analyses of inpatient mortality
(Table V) suggested a signiﬁcantly lower (ie, P value less
than the Simes false discovery rate of P < .023) odds of
almost $50% for open procedures with no amputations
in 2009 (OR2009 ¼ 0.30). Decreased odds of inpatient
mortality of approximately #50% were observed for several
years involving EVT without amputations (OR2004 ¼ 0.47,
OR2007 ¼ 0.37, OR2008 ¼ 0.29, OR2009 ¼ 0.37,
OR2010 ¼ 0.36).
Signiﬁcantly increased charges (ie, P value less than the
Simes false discovery rate of P < .023) were observed over
time for most procedures and amputation status
(Table VI), with the exception of no signiﬁcant change
noted with open procedure with major amputation. Hospi-
tal LOS decreased by approximately 10% to 25% across
most of the groups by 2009 or 2010.
DISCUSSION
This investigation of revascularization procedures in
DFU cases provides nationally-representative clinical and



























Percentage No. Percentage No. Percentage No. Percentage No. Percentage No. Percentage No.
Any surgical complication 22.8 654 14.4 2846 14.1 9767 15.5 5152 7.3 1312 4.8 4043
Cardiac 2.9 84 2.2 427 2.5 1711 1.4 86 0.8 148 0.6 490
Stroke 0.4 11 0.1 29 0.1 99 0.1 5 0.0 0 0.1 39
Respiratory 4.2 122 1.7 327 2.1 1428 2.1 129 0.7 127 0.5 397
Bleeding 12.0 345 9.0 1773 8.4 5850 9.9 604 4.3 774 2.3 1973
Infection 8.0 228 2.5 494 2.3 1622 3.5 210 1.8 329 1.6 1372
Shock 0.7 20 0.2 30 0.1 67 0.1 5 0.1 10 0.1 57
Died during hospitalization 6.3 179 1.4 278 1.5 1059 6.3 384 1.2 222 1.4 1172
Table III. Descriptive statistics of clinical outcomes, stratiﬁed according to procedure
Outcome assessments
Open bypass procedure











Percentage No. Percentage No. Percentage No. Percentage No.
Amputation 24.6 22,615 22.2 23,988 30.1 3429 23.7 50,032
Major 3.1 2865 5.6 6096 5.6 638 4.5 9600
Minor 21.5 19,750 16.5 17,882 24.5 2791 19.1 40,422
Any surgical complication 14.4 13,267 5.8 6300 16.6 1889 10.1 21,455
Cardiac 2.4 2222 0.7 723 2.4 279 1.5 3224
Stroke 0.2 139 0.1 45 0.4 45 0.1 228
Respiratory 2.0 1877 0.6 654 2.7 303 1.3 2834
Bleeding 8.7 7968 3.1 3350 9.6 1090 5.9 12,408
Infection 2.5 2344 1.8 1911 3.1 349 2.2 4604
Shock 0.1 117 0.1 72 0.2 21 0.1 209
Died during hospitalization 1.7 1516 1.6 1778 2.5 288 1.7 3582
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from 2001 to 2010. Overall, 16.5% of the 2.5 million total
DFU cases involved an amputation (n ¼ 412,057), of
which almost half underwent any revascularization proce-
dure (n ¼ 211,534). The total national bill summed to
$18.99 billion (USD 2012) with a case mortality rate of
9.3% and a surgical case complication rate of 10.1%. Con-
cerning single-procedure cases only, the highest charges
involved open procedures with major amputations at
$194,413 (USD 2012), also incurring the highest surgical
complication rate of 22.8% and longest LOS of 27.2 days.
Open procedure volume declined sharply during the
study’s time frame and was paralleled by marked increases
in EVT volume, conﬁrming reports that have observed a
paradigm shift in the management of lower extremity pe-
ripheral artery disease, even for limb salvage cases.6-10 We
also found improvements concerning short-term inpatient
mortality, with a signiﬁcant reduction of 19.1% in the crude
case rate from 2001 to 2010. After adjusting for key
covariates (ie, sociodemographic attributes, hospital char-
acteristics, comorbid conditions), signiﬁcant and consistentreductions in inpatient death were observed among cases
particularly involving EVT without amputations (ie,
2006-2010 vs 2001). Results of the stratiﬁed multivariate
analyses of surgical complications suggested instances in
which outcomes worsened over time, as large and signiﬁ-
cantly greater odds of surgical complications among EVT
with major amputations began in 2007 (vs 2001), reaching
a maximum of 1008.2% in 2010. An increased rate of com-
plications was also noted among open procedures with
either minor or no amputations. Regarding economic out-
comes, hospital LOS was observed to decrease for most
procedures and amputation types, and inﬂation-adjusted
charges generally increased.
To place the current study in perspective, Goodney
et al reported that for every single lower extremity bypass
performed, three EVT interventions were conducted in
an examination of Medicare part B claims from 1996 to
2006; EVT also increased 229.8% (from 138 to 455 proce-
dures per 100,000 beneﬁciaries) and open bypass
decreased 42% (from 219 to 126 per 100,000 beneﬁ-
ciaries).6 Egorova et al noted a 209% increase in EVT

































complicationa OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
2001 (baseline)
2002 0.63 0.23-1.69 0.94 0.56-1.57 1.07 0.84-1.36 3.54 0.37-33.50 3.20 0.98-10.42 0.76 0.43-1.34
2003 1.78 0.71-4.45 1.13 0.77-1.66 0.92 0.73-1.16 6.19 0.77-49.76 2.71 0.84-8.75 1.04 0.64-1.68
2004 1.67 0.69-4.05 1.53 1.04-2.25 1.19 0.94-1.51 7.18 0.90-57.34 2.21 0.71-6.89 0.98 0.62-1.56
2005 1.81 0.67-4.85 1.20 0.76-1.89 1.08 0.83-1.41 7.71 0.95-62.50 2.12 0.69-6.49 1.15 0.74-1.78
2006 1.30 0.52-3.22 1.25 0.83-1.89 1.08 0.85-1.37 5.84 0.74-45.98 2.28 0.77-6.76 0.81 0.52-1.26
2007 1.35 0.45-4.02 1.29 0.81-2.04 1.25 0.99-1.58 11.27b 1.48-85.70 2.64 0.90-7.76 0.81 0.53-1.25
2008 2.26 0.83-6.12 1.66 1.11-2.48 1.64b 1.27-2.13 8.36 1.10-63.79 2.76 0.95-8.04 0.96 0.63-1.45
2009 2.15 0.77-6.02 1.77b 1.15-2.72 1.37b 1.07-1.75 11.36b 1.45-89.10 2.95 1.00-8.69 1.09 0.71-1.68
2010 2.73 0.92-8.17 1.74b 1.11-2.73 1.53b 1.18-2.00 11.80b 1.55-90.16 2.73 0.93-7.96 1.04 0.67-1.59
Surgical complication,
No. (sum)c IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI
2001 (baseline)
2002 0.75 0.30-1.85 0.92 0.58-1.44 1.10 0.87-1.37 3.33 0.38-29.16 3.00 0.98-9.19 0.81 0.47-1.39
2003 1.96 0.90-4.30 1.08 0.76-1.53 0.95 0.77-1.17 6.15 0.81-46.45 2.90 0.94-8.97 1.04 0.66-1.66
2004 1.30 0.62-2.73 1.34 0.98-1.95 1.20 0.97-1.48 7.68 1.02-57.89 2.14 0.72-6.37 1.02 0.64-1.60
2005 1.40 0.64-3.07 1.20 0.80-1.80 1.08 0.85-1.37 7.33 0.97-55.44 2.16 0.73-6.38 1.20 0.78-1.84
2006 1.01 0.47-2.15 1.18 0.82-1.69 1.08 0.87-1.34 6.05 0.82-44.81 2.25 0.79-6.38 0.81 0.53-1.23
2007 1.39 0.57-3.40 1.25 0.82-1.89 1.26b 1.01-1.56 9.99b 1.39-71.85 2.50 0.89-7.03 0.85 0.56-1.29
2008 1.68 0.74-3.82 1.52b 1.06-2.16 1.53b 1.23-1.89 9.06b 1.25-65.72 2.88 1.03-8.05 0.99 0.66-1.49
2009 1.35 0.60-3.03 1.56b 1.08-2.27 1.33b 1.07-1.66 10.64b 1.45-78.34 2.97 1.05-8.39 1.07 0.71-1.62
2010 1.77 0.78-4.00 1.74b 1.19-2.56 1.43b 1.14-1.79 10.70b 1.48-77.23 2.78 0.99-7.79 1.03 0.68-1.55
Inpatient deatha OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
2001 (baseline)
2002 2.73 0.55-13.67 1.06 0.39-2.93 0.70 0.41-1.18 1.04 0.24-4.43 0.29 0.03-2.77 0.61 0.29-1.29
2003 5.60 0.98-31.94 0.91 0.29-2.80 0.58 0.32-1.05 0.90 0.25-3.32 0.32 0.05-2.13 0.92 0.47-1.81
2004 3.04 0.61-15.06 0.89 0.24-3.33 0.76 0.44-1.34 0.51 0.11-2.38 1.06 0.23-4.83 0.47 0.23-0.99
2005 5.44 1.02-28.95 1.09 0.35-3.43 0.79 0.45-1.41 0.77 0.21-2.88 0.46 0.10-2.11 0.67 0.35-1.28
2006 0.86 0.07-9.93 1.23 0.39-3.87 0.73 0.41-1.31 0.86 0.25-2.98 0.45 0.10-1.92 0.61 0.34-1.11
2007 1.16 0.19-12.33 0.55 0.16-2.12 0.50 0.26-0.96 0.58 0.16-2.08 0.37 0.09-1.48 0.37b 0.19-0.69
2008 1.70 0.19-15.25 0.93 0.29-3.00 0.63 0.34-1.17 0.22 0.05-0.96 0.40 0.09-1.66 0.29b 0.15-0.58
2009 1.12 0.09-14.70 0.37 0.08-1.73 0.30b 0.13-0.69 0.26 0.06-1.11 0.17 0.03-0.89 0.37b 0.19-0.69
2010 0.85 0.07-10.61 0.58 0.16-2.13 0.55 0.28-1.09 0.61 0.17-2.23 0.17 0.03-0.93 0.36b 0.19-0.67
CI, Conﬁdence interval; IRR, incidence rate ratio; OR, odds ratio.
Multivariate models were adjusted for: patient demographic characteristics (age, sex, income level), hospital characteristics (bed size, geographic region,
urban/rural location, teaching status), and Deyo-Charlson Comorbidity Index (case-mix comorbid risk adjustor/disease complexity).
aGeneralized linear model, binomial/logistic.
bStatistical signiﬁcance less than the computed Simes false discovery rate P value (P < .023).
cGeneralized linear model, Poisson.
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39% in open revascularizations (from 111 to 68 per
100,000 population) among inpatient cases from 1998 to
2007.7 Concerning critical limb ischemia cases in North
Carolina in 1996 and 2005, Cull et al found a 255% in-
crease for EVT (from 151 to 385 total cases) and an 11%
decrease for open procedures (from 420 to 373 total
cases).9 Comparatively, in the current study we found an
increase in EVT of 126.3% (from 2570 to 5815 per
100,000 DFU cases) and a decrease in open bypass of
49.6% (from 5855 to 2902 per 100,000 DFU cases).Relating to amputations, from 1996 vs 2006, Goodney
et al reported a 28.5% decrease (from 263 to 188 per
100,000 beneﬁciaries), and Egorova et al found a decrease
of 38% (from 59 to 37 per 100,000 population) from 1998
vs 2007.6,7 Although most cases in Egorova et al involved
critical limb ischemia and peripheral artery disease, diabetes
was present in 60% of critical limb ischemia cases and 30%
of claudication cases.7 In the present study, the overall crude
amputation case rate was markedly higher, and did not appre-
ciably change between 2001 and 2010 (from 16,476 to
16,702 per 100,000 DFU cases); minor amputations


























Chargesa exp(b) 95% CI exp(b) 95% CI exp(b) 95% CI exp(b) 95% CI exp(b) 95% CI exp(b) 95% CI
2001 (baseline)
2002 1.09 0.81-1.47 1.14 0.95-1.36 1.09 0.98-1.21 1.17 0.85-1.62 1.10 0.92-1.31 1.11 0.99-1.23
2003 1.34 1.01-1.77 1.19b 1.04-1.35 1.19b 1.08-1.30 1.24 0.96-1.60 1.43b 1.17-1.75 1.29b 1.16-1.44
2004 1.27 0.97-1.66 1.17b 1.04-1.32 1.21b 1.09-1.34 1.27 0.95-1.68 1.33b 1.16-1.53 1.34b 1.20-1.50
2005 1.17 0.87-1.58 1.18b 1.03-1.36 1.18b 1.06-1.30 1.27 0.99-1.62 1.45b 1.24-1.70 1.47b 1.30-1.66
2006 1.12 0.87-1.45 1.25b 1.09-1.44 1.22b 1.10-1.36 1.43b 1.13-1.80 1.38b 1.20-1.57 1.38b 1.24-1.52
2007 1.18 0.91-1.53 1.24b 1.09-1.42 1.17b 1.06-1.28 1.39b 1.08-1.78 1.39b 1.22-1.58 1.40b 1.25-1.56
2008 1.18 0.90-1.55 1.24b 1.08-1.42 1.18b 1.07-1.31 1.37b 1.09-1.72 1.45b 1.26-1.67 1.49b 1.33-1.67
2009 1.13 0.81-1.58 1.29b 1.11-1.50 1.21b 1.08-1.35 1.36b 1.09-1.69 1.38b 1.21-1.58 1.55b 1.39-1.72
2010 1.23 0.92-1.65 1.36b 1.16-1.58 1.33b 1.19-1.49 1.38b 1.10-1.73 1.40b 1.23-1.60 1.64b 1.47-1.83
LOSc IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI
2001 (baseline)
2002 0.93 0.76-1.13 1.00 0.92-1.09 0.99 0.92-1.07 0.95 0.74-1.22 1.05 0.90-1.23 1.08 0.94-1.24
2003 0.96 0.78-1.17 1.00 0.91-1.10 0.98 0.91-1.04 0.95 0.74-1.21 1.12 0.95-1.29 1.08 0.95-1.23
2004 1.06 0.85-1.33 0.98 0.90-1.07 0.99 0.92-1.07 0.93 0.72-1.19 1.05 0.92-1.21 1.05 0.92-1.18
2005 0.94 0.75-1.16 0.98 0.89-1.08 0.93 0.87-1.00 0.92 0.73-1.17 1.07 0.94-1.22 1.05 0.94-1.18
2006 0.91 0.76-1.09 1.00 0.91-1.10 0.89b 0.82-0.95 0.99 0.79-1.24 1.01 0.89-1.15 0.94 0.83-1.08
2007 0.89 0.72-1.09 0.96 0.87-1.05 0.82b 0.76-0.88 0.94 0.73-1.21 0.99 0.87-1.12 0.88 0.77-0.99
2008 0.93 0.74-1.17 0.91 0.83-1.00 0.81b 0.75-0.88 0.87 0.70-1.09 0.95 0.82-1.08 0.92 0.80-1.05
2009 0.71b 0.54-0.95 0.85b 0.77-0.94 0.76b 0.70-0.82 0.78 0.63-0.97 0.91 0.81-1.03 0.92 0.81-1.04
2010 0.75b 0.60-0.94 0.88b 0.80-0.97 0.82b 0.76-0.89 0.76b 0.61-0.96 0.85b 0.75-0.95 0.91 0.81-1.03
CI, Conﬁdence interval; exp(b), exponentiated beta coefﬁcient; IRR, incidence rate ratio, LOS, length of stay.
Multivariate models were adjusted for: patient demographic characteristics (age, sex, income level), hospital characteristics (bed size, geographic region,
urban/rural location, teaching status), and Deyo-Charlson Comorbidity Index (case-mix comorbid risk adjustor/disease complexity).
aGeneralized linear model, gamma.
bStatistical signiﬁcance less than the computed Simes false discovery rate P value (P < .023).
cGeneralized linear model, negative binomial.
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5.7%. In observing decreased number of amputations with
increased EVT, Goodney et al suggested that improvements
of care might have occurred, noting that a more critical eval-
uation of comorbidities and podiatric care was still
required.6,17,18 These authors suggested that improved access
to podiatric care, more frequent testing for hemoglobin A1c,
and hyperlipidemia treatment might have also contributed to
improved outcomes.6 Despite this, and more consistent with
the current study’s results, Anderson et al found 10-fold in-
creases in endovascular procedures with no notable change
in amputations across inpatient hospitalizations in the United
States from 1980 to 2000.10 Cull et al also reported no signif-
icant changes in amputation rates between 1995 and 2006
among critical limb ischemia revascularization cases in South
Carolina.9 Although Goodney et al commented that the
period of decline for amputations followed the time horizon
analyzed by Anderson et al, ﬁndings from the current work
did not suggest a signiﬁcant proportional change in overall
amputation rate among DFU cases.6,10 The large increase
in EVT that occurred without a change in amputation rates
might suggest that either EVT was required to yield similar
results as open, or that a larger number of procedures were
performed than were required for actual limb salvage.Concerning surgical complications, Egorova et al re-
ported no changes among major amputations with revascu-
larization in 1998 vs 2007 involving crude rates of cardiac
complications, postoperative stroke, respiratory complica-
tions, or infection; bleeding, however, was found to
decrease signiﬁcantly (from 23.1% to 16.7%; P ¼
.0004).7 Diabetes, in particular, was found to be associated
with >60% of major amputations, although the number of
revascularization-associated complications in this high-risk
cohort was found to decrease over time.7 Comparatively,
changes in the crude rates among speciﬁc categories of
complications in 2001 vs 2010 among major amputation
with revascularizations across all DFU cases were un-
changed for cardiac, stroke, respiratory, and infection.
Bleeding, however, was found to signiﬁcantly increase
from 5.00% to 17.53% (P < .001), comprised of bleeding
in EVT (from <0.01% to 14.77%; P < .001) vs open
(from 9.37% to 26.27%; P < .001). Results of the current
study’s stratiﬁed multivariate analyses did not uniformly
support the conclusion of Egorova et al, because the
presence of any surgical complication was noted to
increase signiﬁcantly for endovascular procedures with ma-
jor amputations.7 To a lesser extent, complications
increased among open procedures with either minor
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complications between open and EVT remained similar,
which might suggest that less-invasive approaches might
not translate to decreased risk overall, particularly if
repeated procedures are ultimately required. Regardless,
evidence suggests improvement in clinical outcomes with
repeated target extremity revascularization among patients
with diabetes and those without, and that current standards
of care yield similar outcomes in terms of limb salvage, sur-
vival, and major amputations.19,20 In this context, Cull et al
reported a signiﬁcant increase from 8% to 19% of critical
limb ischemia cases in North Carolina requiring additional
revascularization in the same calendar year in 1996 and
2005, respectively (P < .001).9
Collectively, the large economic effect of amputations
despite EVT or bypass implies the need to develop and vali-
date risk stratiﬁcation for patients who might or might not
beneﬁt from costly and potentially risky procedures. In the
current work, costs from the perspective of the payer were
generally found to increase from 2001 across almost all
procedures and amputation categories, with the largest sig-
niﬁcant increases in 2010 vs 2001 observed among endo-
vascular procedures (major amputation ¼ 37.9%, minor
amputation ¼ 40.1%, no amputation ¼ 64.0%). Similarly,
in 2010, LOS was found to either decrease or remain con-
stant vs 2001, particularly among open procedures (major
amputation ¼ 25.0%, minor amputation ¼ 12.0%, no
amputation ¼ 18.2%). Across all DFU cases in the United
States from 2001 to 2010, irrespective of revascularization
procedures, Skrepnek et al reported increased charges of
16.7% and a decreased LOS of 23.6%.21 Nguyen et al
analyzed resource utilization within the Project of Ex-Vivo
vein graft Engineering via Transfection III (PREVENT III)
clinical trial of critical limb ischemia patients who received
lower extremity bypass, and reported an initial, index LOS
of 8.8 days and cumulative LOS of 24.8 days after an average
of 1.5 hospitalizations across the 1-year study period.22
Factors including advanced age, complications, and illness
severity were among those found to be strongly associated
with inpatient mortality or resource utilization by Kazmers
et al.23 Althoughwe did not explicitly report results of socio-
economic factors (eg, income, geographic location, hospital
characteristics), control for these key attributes was indeed
undertaken within the multivariate analysis; inclusion of
these variables is required based on economic theory and
previous clinical work.7,8,24-29 To illustrate, Durham et al
assessed the association between socioeconomic status, clin-
ical outcomes, and inpatient hospital costs among 187
regional cases of femoropopliteal revascularization from
2003 to 2006, suggesting that lower income levels were
associated with higher per-day cost of patency and inferior
limb salvage.24 Furthermore, comorbidities including coro-
nary artery disease, heart failure, diabetes, and hypertension
were also not found to be associated with the study’s out-
comes. Goodney et al also assessed geographic differences
in vascular care procedures and amputation rates among
Medicare beneﬁciaries from 2003 to 2006, and suggested
that regions of high-intensity vascular care (ie, lowerextremity vascular procedures) were associated with
decreased likelihoods of amputationswithout preliminary at-
tempts at revascularization.29
Although in the current investigation we used
nationally-representative data for revascularizations among
DFU cases, potential limitations should be addressed.
Despite analyses that controlled for key factors known to
be associated with outcomes and because these data were
not explicitly administrative claims, other unmeasurable or
exogenous factors might be of importance in interpreting
ﬁndings including reimbursement coding changes and the
dataset’s lack of ability to stratify according to indication,
extent of wound, degree of ischemia, and severity of infec-
tion.30 Although a validated case-mix comorbidity index
and method to identify DFUs was used, speciﬁc clinical
criteria to establish detailed revascularization types, speciﬁc
ischemic ulcers, or infection severity beyond broad diag-
nostic criteria was not present, nor was information relating
to ambulatory care.12,13 The unit of analysis was also that of
a speciﬁc inpatient admission rather than of a speciﬁc pa-
tient, hence, the methodological framework could not
explicitly identify multiple visits by the same person. Because
explicit longitudinal analysis of the individuals could not be
undertaken, certain ﬁndings (eg, case mortality) might be
markedly underestimated because of hospital readmissions.
Furthermore, the broad inclusion criteria to identify DFU
cases did not necessarily preclude these as being the principal
reason or diagnosis associated with the inpatient admis-
sion.12 Generalizing ﬁndings from this work to speciﬁc, in-
dividual hospital systems or patients should therefore be
undertaken with caution. Despite these potential limita-
tions, the current study builds on previous research through
its explicit empirical control for key factors related to out-
comes rather than only crude, unadjusted ﬁndings. Future
avenues of research in assessing cost, outcomes, and access
to care in patients withDFUsmight seek to include compre-
hensive analyses across all health care settings in addition to
disease-speciﬁc clinical factors that can ultimately establish
the appropriateness of various revascularization procedures.
CONCLUSIONS
In this nationally-representative investigation, we
found that admissions involving DFUs are common,
long, and costly (often >$100,000 per case), potentially
due in part to the increasing case-severity mix seen within
inpatient settings. More DFU cases involved revasculariza-
tion (8.5% per admission), with a large shift from open
bypass to EVT. It is encouraging to note that hospital mor-
tality and LOS either remained the same or have decreased
signiﬁcantly, and that major amputations for hospitalized
patients with DFU also appear to be ﬂattening with an in-
crease in minor amputations (major:minor ratio ¼ 0.534).
The news is mixed, however, because increases in
procedure-speciﬁc surgical complications and increased
inﬂation-adjusted charges were observed across several inter-
vention categories. Collectively, these ﬁndings characterize
the prevalence, clinical signiﬁcance, and economic effect of
a frequently neglected problem: the DFU.
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Submitted Feb 10, 2014; accepted Apr 29, 2014.DISCUSSIONDr Vincent Rowe (Los Angeles, Calif). The authors’ objective
was to review and report the charges, case complexity, and use of
revascularization among inpatient hospital admissions for diabetic
foot ulcers and associated amputations in the United States overthe past 10 years. To do so, the authors utilized the inpatient
discharge records from the Agency for Healthcare Research and
Quality Healthcare Cost and Utilization Project. The authors do
an excellent job of sorting out such a large volume of information
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complications. With such large databases, there are pros and
cons to the information that is accrued; however, the authors
clearly point out the shortcomings of this database, and therefore
there is no need for me to address those issues. My questions will
mainly be focused on the interpretation of their ﬁndings.
Over the past decade, patients with diabetic foot ulcers had a
shortened length of stay and increased hospital charges. What do
the authors attribute to this ﬁnding? Is it a reﬂection of increased
healthcare costs, are we driving up the costs with increased endo-
vascular procedures, or are the cases becoming more complex?
Dr Grant H. Skrepnek. Healthcare costs are an important
proxy that reﬂect the intensity of interventions and resources pro-
vided in clinical practice. The observation of increased charges with
decreased lengths of stay is complex and suggests, at least superﬁ-
cially, an increasing extent of inpatient care that allows patients to
be discharged more rapidly. Despite this, the current study’s out-
comes also reﬂect other dimensions, including the adoption of
medical technologies, evolving standards of care, price inﬂation,
and changes in patient case-mix. In this context, signiﬁcant in-
creases in the overall case-mix complexity were indeed observed
via either the Elixhauser or Deyo-Charlson Comorbidity Index.
However, a key limitation in most nationally representative data-
base work involves the lack of speciﬁc diabetic foot ulcer (DFU)-
related risk factors that capture the degree of ischemia, severity
of infection (if present), and other wound characteristics. While
either the diffusion of endovascular procedures or the increase in
overall case-complexity may indeed explain an observation of
increased charges, ceteris parabis, large-scale longitudinal analyses
incorporating these disease-speciﬁc measures would be helpful in
determining the comparative effectiveness of vascular interven-
tions. Finally, although not measured in the current work, the
quality of ambulatory care would intuitively be expected to inﬂu-
ence the potential outcomes within the hospital setting.
Dr Rowe. Did the authors see any difference in complications
and amputations when comparing patients treated in urban large
hospitals versus smaller hospitals?
Dr Skrepnek. Empirically, no systematic differences between
outcomes based on hospital bed size were observed. A ﬁnding thatmay deserve further investigation, however, involves the observa-
tion that lower odds of complications were found in urban (vs ru-
ral) hospitals among endovascular procedures: a 57% reduction in
the odds of complications for cases involving above-ankle amputa-
tions (OR, 0.43; 95% CI, 0.25-0.74; P ¼ .002), and a 32% reduc-
tion involving cases with no amputation (OR, 0.68; 95% CI, 0.49-
0.94; P ¼ .018). While higher charges were often associated with
urban hospitals, this was not necessarily observed across all proce-
dure types or amputation status.
Dr Rowe. Focusing on amputations, the authors state that the
amputation rates are ﬂattening?This is an intriguing issue, as there are
somany factors that can contribute to this clinical ﬁnding.Do the au-
thors think that the rise in endovascular procedures and minor inter-
ventions in an indicator ormarker of increased physician awareness of
the need for specialty (vascular) care of this diabetic population?
Dr Skrepnek. While the number of inpatient cases involving
diabetes has increased from 2001 to 2010, the percentage of those
with DFUs has remained constant, slightly below 4%. Also un-
changed through the decade, approximately 17% of inpatient
DFU cases involved amputations, 9% of DFU cases involve a revas-
cularization procedure, and 24% of revascularized DFU cases
involved an amputation. Despite these observations, an increase
in minor amputations occurred (from 8% to 12% of DFU cases
during the decade), with no change in major above-ankle amputa-
tions (9%-10% of DFU cases). The association between these latter
outcomes and an increase in endovascular interventions (from un-
der 5% of DFU cases to almost 15%) is compelling. While we sup-
port, at least anecdotally, that an increased clinical awareness
surrounding the care of the diabetic foot has occurred, we also
assert that insufﬁcient resources still remain concerning prevention.
Overall, estimates of the economic and clinical burden of illness
associated with DFUs should seek to increase awareness of the
condition, to enhance comparative and cost-effectiveness analyses
of treatment options, and to catalyze the prioritization of clinical
and research efforts to improve prevention and cure.
Dr Rowe. Thank you, Society, for selecting me to review this
interesting manuscript.
Dr Skrepnek. The authors are also appreciative of the
thoughtful and engaging evaluation of this work.
